Evaluation of COMT (rs4680), CNR2 (rs2501432), CNR2 (rs2229579), UCP2 (rs659366), and IL-17 (rs763780) gene variants in synthetic cannabinoid use disorder patients

PEHLİVAN S., Aytac H. M., Kurnaz S., Pehlivan M., Aydin P. C.

JOURNAL OF ADDICTIVE DISEASES, cilt.38, sa.4, ss.495-505, 2020 (SSCI) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 38 Sayı: 4
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1080/10550887.2020.1787770
  • Dergi Adı: JOURNAL OF ADDICTIVE DISEASES
  • Derginin Tarandığı İndeksler: Social Sciences Citation Index (SSCI), Scopus, Academic Search Premier, ASSIA, PASCAL, Agricultural & Environmental Science Database, BIOSIS, CINAHL, Criminal Justice Abstracts, Educational research abstracts (ERA), EMBASE, MEDLINE, Psycinfo, Social services abstracts, Sociological abstracts, Violence & Abuse Abstracts
  • Sayfa Sayıları: ss.495-505
  • Anahtar Kelimeler: COMT, CNR2, UCP2, IL-17, synthetic cannabinoid, O-METHYLTRANSFERASE GENE, UNCOUPLING PROTEIN-2, FUNCTIONAL POLYMORPHISM, COMMON POLYMORPHISM, ASSOCIATION, RECEPTOR, PROMOTER, DISEASE, DEPENDENCE, PSYCHOSIS
  • İstanbul Üniversitesi Adresli: Evet

Özet

Synthetic cannabinoids (SC) are psychoactive drugs that generally produce more severe clinical outcomes compared to Delta 9-tetrahydrocannabinol. This study aimed to evaluate the relationship between clinical features of synthetic cannabinoid use disorder (SCUD) and COMT (rs4680), CNR2 (rs2501432), CNR2 (rs2229579), UCP2 (rs659366), and IL-17 (rs763780) gene variants in SCUD patients by comparing the genotype distributions of gene variants between patients and healthy controls. Based on the DSM-5 criteria, 94 patients with SCUD, confirmed with a positive urine test, and 95 healthy volunteers were included in the study. Self-mutilation, suicidal behavior, psychotic symptoms, drug-induced psychosis, tobacco use disorder (TUD) or alcohol use disorder (AUD) comorbidity, and family history of TUD or AUD were evaluated in all patients. PCR-RFLP was used to identify gene variants from DNA material. The distributions of CNR2 (rs2229579) and UCP2 (rs659366) variants were significantly different in patients diagnosed with SCUD compared to the control group. SC-related psychotic symptoms were associated with the IL-17 (rs763780) variant in SCUD patients who had an onset of SC usage under 18 years of age. While the COMT Val108Met gene variant was related to self-mutilation, the COMT Val158Met variant was associated with attempted suicide. In addition, in SCUD patients, the UCP2 (rs659366) variant was associated with a family history of AUD or TUD. In summary, CNR2 (rs2229579) and UCP2 (rs659366) variants were associated with SCUD. While SC-related psychotic symptoms were related to the IL-17 (rs763780) variant, the COMT variants were associated with self-mutilation or attempted suicide in SCUD patients.